Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

UroGen Pharma (URGN) Inventory Average (2017 - 2025)

Historic Inventory Average for UroGen Pharma (URGN) over the last 8 years, with Q3 2025 value amounting to $7.7 million.

  • UroGen Pharma's Inventory Average rose 287.98% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 287.98%. This contributed to the annual value of $7.4 million for FY2024, which is 4902.98% up from last year.
  • Per UroGen Pharma's latest filing, its Inventory Average stood at $7.7 million for Q3 2025, which was up 287.98% from $7.4 million recorded in Q2 2025.
  • UroGen Pharma's 5-year Inventory Average high stood at $8.4 million for Q4 2024, and its period low was $2.6 million during Q1 2021.
  • In the last 5 years, UroGen Pharma's Inventory Average had a median value of $5.0 million in 2023 and averaged $5.6 million.
  • Per our database at Business Quant, UroGen Pharma's Inventory Average surged by 19255.36% in 2021 and then increased by 22.47% in 2025.
  • Quarter analysis of 5 years shows UroGen Pharma's Inventory Average stood at $4.3 million in 2021, then rose by 6.33% to $4.6 million in 2022, then rose by 16.2% to $5.3 million in 2023, then soared by 57.57% to $8.4 million in 2024, then decreased by 8.04% to $7.7 million in 2025.
  • Its Inventory Average stands at $7.7 million for Q3 2025, versus $7.4 million for Q2 2025 and $8.4 million for Q1 2025.